[#item_full_content] While the Philadelphia litigation (and another Jushi-filed suit) claim that hemp-derived intoxicants usurped the regulated cannabis industry’s market share, two things are clear: the marijuana business is more challenging than anticipated; and the ultimate decision of which intoxicating THC product is preferable ultimately rests in the consumers’ hands. 
Read More
